• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » How to Switch Antipsychotics

How to Switch Antipsychotics

February 3, 2021
Peter Smith, PsyD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Peter Smith, PsyD. Dr. Smith has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Takeuchi H and Remington G, J Psychopharmacol 2020;34(8):914–919


Type of study: Meta-analysis of randomized controlled trials


Antipsychotic switching is a routine part of schizophrenia care, but what’s the best way to go from one medication to another? This article compared three strategies: 1) abruptly stopping the old antipsychotic and starting the new one, 2) gradually tapering the old antipsychotic as soon as the new one is added, and 3) performing “wait-and-gradual” discontinuation (ie, waiting more than 1 day after starting the new antipsychotic before tapering off the old one). Earlier meta-analyses found no differences when comparing options 1 vs 2 and 2 vs 3. This new study compared option 1 (abrupt) with option 3 (wait-and-gradual).


The analysis included 6 comparisons of these switch strategies from randomized controlled trials involving 351 patients with chronic schizophrenia. The primary outcomes were dropouts due to all causes, inefficacy, or intolerability. Secondary outcomes included a variety of measures of psychotic symptoms and antipsychotic side effects. Most of the wait-and-gradual studies tapered off the old antipsychotic over 1 week, though one study took 2 weeks to taper and another took 6 weeks. The average follow-up after the switch was 5 to 6 weeks. Sponsorship of the individual studies was not mentioned, but there was no evidence of publication bias. The meta-analysis received no financial sponsorship.


The main finding was that patients were 1.6 times more likely to drop out for any cause (including but not limited to withdrawal of consent and loss to follow-up) with abrupt vs wait-and-gradual discontinuation. For discontinuation due to inefficacy and intolerability, there was a trend favoring the wait-and-gradual method, but it did not reach statistical significance. There were no significant differences in the various measures of side effects and psychotic symptoms between the two strategies. The main weakness of this meta-analysis was the small number of studies included.


TCPR’s Take
When switching antipsychotics, first add the new one in, then taper the old one off over at least 1 to 2 weeks.

General Psychiatry
KEYWORDS antipsychotics deprescribing pharmacology pharmacology-tips psychopharmacology psychopharmacology_tips psychosis research-update schizophrenia
    Peter Smith, PsyD.

    Autism: The Goal Posts Have Moved

    More from this author
    www.thecarlatreport.com
    Issue Date: February 3, 2021
    SUBSCRIBE NOW
    Table Of Contents
    How to Come Off a Psych Med Part 1: Antipsychotics
    Stimulants and Creativity
    Does Abilify cause more weight gain than Seroquel?
    Are SSRIs Associated With Increased Rates of Violence?
    How to Switch Antipsychotics
    Roundup
    Buspirone: Still Effective After All These Years?
    CME Post-Test - Stopping Psych Meds Part 1, TCPR, February 2021
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.